Implant Sciences Awarded Contract Extension from DHS
Award Supports Continued Development of Novel, Highly Selective Trace Explosives Detector
(Wakefield, Mass., June 18, 2008) -- Implant Sciences Corporation (AMEX: IMX), a high technology supplier of sophisticated systems and sensors for the homeland security market and related industries, today announced $500,000 in follow on funding from the U.S. Department of Homeland Security ("DHS"), Science & Technology ("S&T") Directorate in Washington, DC for a Counter-Improvised Explosive Device Program. This award represents further support of a contract awarded to Ion Metrics, the San Diego based company acquired by the Company in April 2008. The addition of this $500,000 brings the total contract value to approximately $2,707,000.
The focus of this contract is to develop integrated, miniaturized sub-systems for use in the detection and identification of trace explosives. Implant Sciences' new San Diego-based Advanced Technology Group has been actively working on the development of a hyphenated system incorporating a Quadrupole Array Mass Spectrometer (QAMS), a miniature Ion Mobility Spectrometer (IMS) and a Differential Mass Spectrometer (DMS), which would represent a new and novel technological capability for the Company and the security industry.
"The Counter-Improvised Explosive Device Program was created in support of efforts by the Science and Technology Directorate within the Department of Homeland Security to leverage existing resources into new and more effective products to help further protect our country," stated Phillip C. Thomas, President and CEO of Implant Sciences. "Along with partners at the University of Florida and Washington State University, our Advanced Technology Group has made important progress in the development of QMS, IMX and DMS technologies which, when combined, could result in high performance yet lightweight, low cost/power technological capabilities for the detection of explosives, drugs, and other substances."
Mr. Thomas added, "Our expertise in the development of miniaturized mass spectrometers and vacuum pumps, combined with our understanding of the commercialization of devices for explosives and drug detection should provide Implant Sciences with a competitive advantage in the security marketplace. We are pleased the DHS continues to support our efforts in the development of this important technology."
Source : Implant Sciences Corp.
Recent News from Implant Sciences Corp.
previous page 
homepage 
print this page 
tell-a-friend